UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53.
Wang, Q
UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. [electronic resource] - Journal of the National Cancer Institute Jul 1996 - 956-65 p. digital
Publication Type: Journal Article
0027-8874
10.1093/jnci/88.14.956 doi
Alkaloids--pharmacology
Antineoplastic Agents--pharmacology
Burkitt Lymphoma--drug therapy
CDC2 Protein Kinase--drug effects
Cell Division--drug effects
Cell Survival--drug effects
Cisplatin--pharmacology
Colonic Neoplasms--drug therapy
Cyclin B
Cyclin B1
Cyclins--drug effects
Drug Synergism
Flow Cytometry
G2 Phase--drug effects
Gamma Rays
Genes, p53--genetics
Humans
Immunoblotting
Mitotic Index
Mutation
Precipitin Tests
Radiation Dosage
Staurosporine--analogs & derivatives
Tumor Cells, Cultured
UCN-01: a potent abrogator of G2 checkpoint function in cancer cells with disrupted p53. [electronic resource] - Journal of the National Cancer Institute Jul 1996 - 956-65 p. digital
Publication Type: Journal Article
0027-8874
10.1093/jnci/88.14.956 doi
Alkaloids--pharmacology
Antineoplastic Agents--pharmacology
Burkitt Lymphoma--drug therapy
CDC2 Protein Kinase--drug effects
Cell Division--drug effects
Cell Survival--drug effects
Cisplatin--pharmacology
Colonic Neoplasms--drug therapy
Cyclin B
Cyclin B1
Cyclins--drug effects
Drug Synergism
Flow Cytometry
G2 Phase--drug effects
Gamma Rays
Genes, p53--genetics
Humans
Immunoblotting
Mitotic Index
Mutation
Precipitin Tests
Radiation Dosage
Staurosporine--analogs & derivatives
Tumor Cells, Cultured